Cargando…

KIR genotype distribution among patients with multiple myeloma: Higher prevalence of KIR 2DS4 and KIR 2DS5 genes

INTRODUCTION: Natural killer (NK) cells possess an antitumor activity against multiple myeloma cells proven by the susceptibility of plasmocytes to NK lysis. In the early stage of MM, the killing of MM cells is mediated by natural cytotoxicity receptors (NRC) and NKG2D-dependent pathway, while in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoteit, R., Bazarbachi, A., Antar, A., Salem, Z., Shammaa, D., Mahfouz, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287873/ https://www.ncbi.nlm.nih.gov/pubmed/25606456 http://dx.doi.org/10.1016/j.mgene.2014.09.008

Ejemplares similares

KIR genotype distribution among Lebanese patients with Hodgkin's lymphoma
por: Hoteit, Rouba, et al.
Publicado: (2015)

Association of KIR2DL5, KIR2DS5, and KIR2DS1 allelic variation and atopic dermatitis
por: Margolis, David J., et al.
Publicado: (2023)

Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection
por: Wauquier, Nadia, et al.
Publicado: (2010)

Clinical Impact of KIR2DS3 and KIR2DL3 Genes in Neuroblastoma Patients
por: Sezgin, Gülay, et al.
Publicado: (2022)

KIR2DL2/S2 and KIR2DS5 in alcoholic cirrhotic patients undergoing liver transplantation
por: Legaz, Isabel, et al.
Publicado: (2019)

KIR2DL2, KIR2DL5A and KIR2DL5B Genes Induce Susceptibility to Dengue Virus Infection, while KIR3DL3 and KIR2DS5 Confer Protection
por: Tapsoba, Aziz Sidi Aristide, et al.
Publicado: (2022)

Role of KIR3DS1 in human diseases
por: Körner, Christian, et al.
Publicado: (2012)

Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients
por: Deborska-Materkowska, Dominika, et al.
Publicado: (2019)

Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3
por: Moesta, Achim K., et al.
Publicado: (2012)

Evaluation of KIR3DL1/KIR3DS1 allelic polymorphisms in Kenyan children with endemic Burkitt lymphoma
por: Muriuki, Beatrice M., et al.
Publicado: (2023)

Protective genotypes in HIV infection reflect superior function of KIR3DS1(+) over KIR3DL1(+) CD8(+) T cells
por: Zipperlen, Katrin, et al.
Publicado: (2014)

KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing
por: Carlomagno, Simona, et al.
Publicado: (2017)

Self-Association of an Activating Natural Killer Cell Receptor, KIR2DS1
por: Hayley, Michael, et al.
Publicado: (2011)

Does the KIR2DS5 Gene Protect from Some Human Diseases?
por: Nowak, Izabela, et al.
Publicado: (2010)

Peptide-specific engagement of the activating NK cell receptor KIR2DS1
por: Chapel, Anaïs, et al.
Publicado: (2017)

Rituximab response in follicular lymphoma: contributions from KIR 2DS1 and HLA-C
por: Erbe, A K, et al.
Publicado: (2013)

Activating KIR2DS4 Is Expressed by Uterine NK Cells and Contributes to Successful Pregnancy
por: Kennedy, Philippa R., et al.
Publicado: (2016)

A novel antibody combination to identify KIR2DS2(high) natural killer cells in KIR2DL3/L2/S2 heterozygous donors
por: Blunt, Matthew D., et al.
Publicado: (2019)

KIR2DS5 in the presence of HLA-C C2 protects against endometriosis
por: Nowak, Izabela, et al.
Publicado: (2015)

Novel Approach to Cell Surface Discrimination Between KIR2DL1 Subtypes and KIR2DS1 Identifies Hierarchies in NK Repertoire, Education, and Tolerance
por: Le Luduec, Jean-Benoît, et al.
Publicado: (2019)

KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A(*)11 while diminishing avidity for HLA-C
por: Graef, Thorsten, et al.
Publicado: (2009)

Are the KIR3DS1homozygous and KIR3DL1*h/*y+HLA-B*57 genotypes associated protection from HIV by different routes of exposure?
por: Tallon, B, et al.
Publicado: (2012)

Peptide-Dependent Recognition of HLA-B*57:01 by KIR3DS1
por: O'Connor, Geraldine M., et al.
Publicado: (2015)

Multiple sclerosis is accompanied by lack of KIR2DS1 gene: A meta-analysis
por: Shahsavar, Farhad, et al.
Publicado: (2016)

KIR3DL05 and KIR3DS02 Recognition of a Nonclassical MHC Class I Molecule in the Rhesus Macaque Implicated in Pregnancy Success
por: Nicholas, Rachel E., et al.
Publicado: (2022)

Association of Functional Polymorphisms of KIR3DL1/DS1 With Behçet's Disease
por: Castaño-Núñez, Ángel, et al.
Publicado: (2019)

The Loss of HLA-F/KIR3DS1 Ligation Is Mediated by Hemoglobin Peptides
por: Hò, Gia-Gia T., et al.
Publicado: (2020)

Functional consequences of Kir2.1/Kir2.2 subunit heteromerization
por: Panama, Brian K., et al.
Publicado: (2010)

Discovery, Characterization, and Structure–Activity Relationships of an Inhibitor of Inward Rectifier Potassium (Kir) Channels with Preference for Kir2.3, Kir3.X, and Kir7.1
por: Raphemot, Rene, et al.
Publicado: (2011)

Two New Cases of KIR3DP1, KIR2DL4-Negative Genotypes, One of which is also Lacking KIR3DL2
por: Niepiekło-Miniewska, Wanda, et al.
Publicado: (2014)

Protective effect of KIR3DS1 in asymptomatic HIV-1 seroconverters towards AIDS
por: Stalinraja, M, et al.
Publicado: (2012)

Conjunctival Scarring in Trachoma Is Associated with the HLA-C Ligand of KIR and Is Exacerbated by Heterozygosity at KIR2DL2/KIR2DL3
por: Roberts, Chrissy h., et al.
Publicado: (2014)

KIR2DS4基因及其变异体KIR1D对同胞全相合造血干细胞移植预后的影响
Publicado: (2015)

High-resolution human KIR genotyping
por: Downing, Jonathan, et al.
Publicado: (2022)

NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts
por: Isitman, Gamze, et al.
Publicado: (2016)

Crystal Structure of the Human Natural Killer Cell Activating Receptor KIR2DS2 (CD158j)
por: Saulquin, Xavier, et al.
Publicado: (2003)

Modulation of Human Leukocyte Antigen-C by Human Cytomegalovirus Stimulates KIR2DS1 Recognition by Natural Killer Cells
por: van der Ploeg, Kattria, et al.
Publicado: (2017)

Diversity of Killer Cell Immunoglobulin-Like Receptor (KIR) Genotypes and KIR2DL2/3 Variants in HCV Treatment Outcome
por: Vidal-Castiñeira, Jose Ramón, et al.
Publicado: (2014)

Linkage disequilibrium organization of the human KIR superlocus: implications for KIR data analyses
por: Gourraud, Pierre-Antoine, et al.
Publicado: (2010)

Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer
por: Borrero-Palacios, A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4npc8a1f9bd3nq6ooufjsojpg0